ERAS Competitors & Alternatives
Compare Erasca Inc with similar stocks in the same industry
Biotechnology
ERAS
Main Stock$15.14
Tradestie Score
64
Market Cap
$626.91M
Analyst Upside
+59.3%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$19.48
|
$6.03B | - | 55 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$55.30
|
$6.02B | - | 55 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$181.81
|
$5.92B | - | 44 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$54.49
|
$5.80B | 20.4 | 51 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$329.22
|
$5.20B | 41.7 | 62 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$56.45
|
$4.94B | - | 52 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$63.96
|
$4.93B | - | 47 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$66.08
|
$4.84B | - | 68 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 50 | Compare |
More ERAS Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry